|
|
Need for early intervention
|
|
|
|
New concepts and guidelines
|
|
|
|
Clinical presentation of CAD
|
|
|
|
Frequency and mortality
|
|
|
|
Recommendations risk estimation
|
|
|
|
Estimated risk as a function
|
|
|
|
SCORE charts with HDL-C
|
|
|
|
Intervention strategies
|
|
|
|
Recommendations for lipid analyses
|
|
|
|
European Guidelines on CVD prevention
|
|
|
|
Recommendations for genetic testing
|
|
|
|
Comparison of different biomarkers
|
|
|
|
Recommendations on management of hyperlipidaemia
|
|
|
|
evidence for a benefit of statin therapy
|
|
|
|
evidence for a benefit of statin therapy
|
|
|
|
Major vascular events avoided
|
|
|
|
Recommendations for treatment targets for LDL-C
|
|
|
|
JAMA. 2012 Mar 28;307(12):1302-9
|
|
|
|
Comparison HPS2-THRIVE and Aim-High trial
|
|
|
|
Lipid-targeted Therapies
|
|
|
|
HDL metabolism
|
|
Download as PPT (PPTX 6.5MB)
Share this page with your colleagues and friends: